Steven Cohen’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-100,000
Closed -$949K – 2218
2025
Q1
$949K Buy
+100,000
New +$1.39M ﹤0.01% 1466

Other funds holding CAPR

Steven Cohen's CAPR Position: Q3 2026 in Review

Steven Cohen increased its Capricor Therapeutics (CAPR) stake by 609% in Q3 2026, buying an estimated $6.39M and bringing the position to 671,505 shares worth $6.36M. The position accounts for 0.01% of the portfolio, ranked #1651.

Steven Cohen first reported a position in CAPR in Q3 2024 and has held it in 6 quarters since. The position peaked at $53.1M in Q4 2025. 156 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.

  • Steven Cohen held 671,505 shares of Capricor Therapeutics worth $6.36M as of Q3 2026.
  • Steven Cohen bought 576,782 Capricor Therapeutics shares in Q3 2026, an estimated $6.39M.
  • Capricor Therapeutics made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1651 holding.
  • Steven Cohen first reported a position in Capricor Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • Steven Cohen's Capricor Therapeutics position peaked at $53.1M in Q4 2025.
  • 156 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.